Quick Dispatch:
Your crohn's disease and glp-1 Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your crohn's disease and glp-1 Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology ships.
Need Help?
Questions about crohn's disease and glp-1 Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for crohn's disease and glp-1 Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology in your area.
A surprising role for enteroendocrine cells and GLP-1 in regulating intestinal inflammation
26.62
Recommendations for the safe and effective use of GLP-1 RA in people
23.66
GLP-1 Medications: Reimagining the Treatment Paradigm for Severe Crohn's Disease
20.60
New research published in the Foundation's journal Crohn's & Colitis 360 found that people with IBD who use GLP-1 medications—commonly prescribed for diabetes and obesity—had a lower risk of major heart-related complications
27.91
GLP-1RAs for IBD
27.23
The Potential for GLP-1s in the Treatment of Crohn's Disease
20.41
The alleviating effect and mechanism of GLP-1 on ulcerative colitis
24.75
